STEPHENSON BRIAN C

CIK 1780030
Transactions on file
30
Open-market buys
22
Win rate (buys)
100%
22 scored
Avg % since filing (buys)
+17.0%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-07-022026-07-01FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy600$14.5K+16.8%open →
2026-07-022026-07-01FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy4,400$103.0K+20.9%open →
2026-07-022026-06-30FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy4,255$106.3K+13.3%open →
2026-07-022026-06-30FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,638$39.1K+18.5%open →
2026-07-022026-06-30FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,910$43.8K+23.3%open →
2026-07-022026-06-29FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy831$19.4K+21.2%open →
2026-06-262026-06-26FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy100$2.6K+7.2%open →
2026-06-262026-06-26FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,358$34.7K+10.7%open →
2026-06-262026-06-26FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy4,212$104.9K+13.6%open →
2026-06-262026-06-26FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy580$13.7K+19.8%open →
2026-06-262026-06-24FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy100$2.8K+1.9%open →
2026-06-262026-06-24FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy3,400$91.7K+4.9%open →
2026-06-262026-06-24FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy3,000$77.9K+8.9%open →
2026-06-262026-06-24FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy2,891$72.9K+12.2%open →
2026-06-242026-06-23FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy425$11.0K+9.2%open →
2026-06-242026-06-23FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,969$48.9K+13.9%open →
2026-06-242026-06-23FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy6,836$164.9K+17.3%open →
2026-06-242026-06-22FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy356$8.5K+18.1%open →
2026-06-242026-06-22FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy3,329$77.5K+21.5%open →
2026-06-242026-06-22FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,583$35.5K+26.3%open →
2026-06-242026-06-22FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,118$23.3K+35.9%open →
2026-06-242026-06-22FTH
Faeth Therapeutics, Inc.
Chief Financial Officer
Buy1,797$36.4K+39.8%open →
2025-01-302025-01-28BBIO
BridgeBio Pharma, Inc.
Officer
Secretary, Treasurer & CFO
Exer.68,000$1.16M+394.2%open →
2025-01-302025-01-28BBIO
BridgeBio Pharma, Inc.
Officer
Secretary, Treasurer & CFO
Sale68,000$2.47M+131.5%open →
2025-02-192025-02-16BBIO
BridgeBio Pharma, Inc.
Officer
Secretary, Treasurer & CFO
Exer.25,798open →
2025-02-192025-02-16BBIO
BridgeBio Pharma, Inc.
Officer
Secretary, Treasurer & CFO
Tax13,102$457.3K+140.7%open →
2025-02-192025-02-19BBIO
BridgeBio Pharma, Inc.
Officer
Secretary, Treasurer & CFO
Sale4,148$150.0K+132.4%open →
2025-02-272025-02-25BBIO
BridgeBio Pharma, Inc.
Officer
CFO and Treasurer
Exer.8,500$144.5K+394.2%open →
2025-02-272025-02-25BBIO
BridgeBio Pharma, Inc.
Officer
CFO and Treasurer
Sale100$3.4K+145.8%open →
2025-02-272025-02-25BBIO
BridgeBio Pharma, Inc.
Officer
CFO and Treasurer
Sale8,400$278.7K+153.2%open →